Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR012016)
Formula Reactant M379-1 Product M365-2/3
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012015 Fruquintinib M379-1 Unclear - Unclear fruquintinib [1], [2]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012017 M379-1 M365-1 Unclear - Unclear fruquintinib [3]
MR012018 M379-1 M555-1 Unclear - Unclear fruquintinib [4]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012020 M379-2 M365-2/3 Unclear - Unclear fruquintinib [5]
MR012012 M379 M365-2/3 Unclear - Unclear fruquintinib [6]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012013 M365-2/3 M365-1 Unclear - Unclear fruquintinib [7]
References
1 Incarceration of the medial collateral ligament in the intercondylar notch following proximal avulsion
2 Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
3 Prophylactic etanercept treatment in cisplatin ototoxicity
4 Biopsychosocial factors predict quality of life in thoracolumbar spine surgery
5 Exhaled breath online measurement for cervical cancer patients and healthy subjects by proton transfer reaction mass spectrometry
6 Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study
7 Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.